BMP4 and neoplasm: Using the subcutaneous xenograft tumor model, we found that BMP4 significantly promoted the growth of subcutaneous tumors, while BAY-876 significantly inhibited BMP4-induced subcutaneous tumor growth from weeks 2 to 4 (Fig. 6B).